IQVIA Laboratories Protein Biomarkers

IQVIA Laboratories Protein Biomarkers – previously called Rules-Based Medicine – delivers tailored biomarker testing to support translational and clinical research. Our team brings proven expertise in assay development and validation, as well as verification of commercial kits. Our lab developed and validated a set of 11 IPF biomarkers utilized by PROLIFIC – the Prognostic Lung Fibrosis Consortium. A subset of 5 biomarkers is now being utilized as part of the PROLIFIC Risk Score.

https://labs.iqvia.com/idiopathic-pulmonary-fibrosis-biomarkers